SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-300042
Filing Date
2023-12-20
Accepted
2023-12-20 17:22:59
Documents
15
Period of Report
2023-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d488420d8k.htm   iXBRL 8-K 42890
2 EX-10.1 d488420dex101.htm EX-10.1 102293
3 EX-99.1 d488420dex991.htm EX-99.1 16970
7 GRAPHIC g488420g1220193204277.jpg GRAPHIC 3501
  Complete submission text file 0001193125-23-300042.txt   325840

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20231220.xsd EX-101.SCH 2842
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20231220_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20231220_pre.xml EX-101.PRE 10807
9 EXTRACTED XBRL INSTANCE DOCUMENT d488420d8k_htm.xml XML 3272
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 231502194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)